推荐产品
等級
analytical standard
品質等級
產品線
VETRANAL®
技術
HPLC: suitable
gas chromatography (GC): suitable
應用
forensics and toxicology
veterinary
格式
neat
SMILES 字串
O=S(C1=CC=C(C2=C(OCC3CC3)C(OC2(C)C)=O)C=C1)(C)=O
InChI
1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3
InChI 密鑰
FULAPETWGIGNMT-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
相关类别
應用
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
推薦產品
Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.
法律資訊
VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
The Journal of veterinary medical science, 82(5), 661-667 (2020-04-03)
The purpose of this study was to evaluate the applicability and feasibility of a novel preoperative planning method for tibial plateau leveling osteotomy (TPLO) based on the width of the proximal tibia. All TPLO procedures were performed by the same
Pharmacokinetics of firocoxib and its interaction with enrofloxacin in horses.
Journal of veterinary pharmacology and therapeutics, 35(6), 615-617 (2012-01-12)
Journal of the American Veterinary Medical Association, 243(2), 225-231 (2013-07-05)
To evaluate the effects of perioperative oral administration of tramadol, firocoxib, and a tramadol-firocoxib combination on signs of pain and limb function after tibial plateau leveling osteotomy in dogs. Randomized, blinded, prospective clinical trial. 30 adult client-owned dogs with unilateral
American journal of veterinary research, 69(11), 1399-1405 (2008-11-05)
To determine pharmacokinetic parameters and variables, firocoxib concentrations in urine and plasma, urine-to-plasma ratios, and the urine depletion profile of firocoxib and to evaluate whether the pharmacokinetic behavior of firocoxib was governed by linear processes after multiple doses of firocoxib
The Veterinary record, 168(23), 617-617 (2011-06-07)
Thirty-nine client-owned dogs with osteoarthritis were treated with 5 mg/kg firocoxib administered orally, once a day for 52 weeks. Veterinary examinations were performed on approximately days 0, 15, 90, 180, 270 and 360. Twenty-five dogs completed the study. The withdrawal
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门